收藏切换
Nanoparticle Drug Delivery Systems for the Treatment of Metabolic Associated Fatty Liver Disease
收藏切换
Qinghui FU, Jie LIU, Jun HE*
Chinese Journal of Pharmaceuticals | 2025, 56(8) : 975 - 983
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(8): 975-983
• Perspectives & Review •
Nanoparticle Drug Delivery Systems for the Treatment of Metabolic Associated Fatty Liver Disease
Full
Qinghui FU, Jie LIU, Jun HE*
Affiliations
  • National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
Published: 2025-08-10 doi: 10.16522/j.cnki.cjph.2025.08.001
Outline
收藏切换

Metabolic associated fatty liver disease(MAFLD) is a liver disease characterized by hepatic steatosis,accompanied by metabolic abnormality. In recent years, the incidence of MAFLD has significantly increased due to lifestyle changes and rising obesity rates, becoming an important public health challenge globally. Despite advancements in mechanistic understanding and escalating research efforts on therapeutic agents, effective pharmacological interventions for MAFLD remain limited. Notably, the development of potential therapeutics is often hindered by critical drawbacks such as poor stability, low bioavailability, and inadequate hepatic targeting. Nanoparticle drug delivery systems offer a promising solution by enhancing drug stability, improving solubility and bioavailability, and enabling precise hepatic targeting. This review primarily introduces the pathogenesis, diagnostic criteria, current treatment status, and challenges in drug development for MAFLD, with a particular focus on the application of nanoparticle drug delivery systems to MAFLD treatment, aiming to provide references for the development of therapeutic drugs for MAFLD.

metabolic associated fatty liver disease  /  fatty liver disease  /  nanoparticle drug delivery system  /  nanoparticle  /  nauoemulsion
付庆辉, 刘洁, 何军. 纳米给药系统在代谢相关脂肪性肝病治疗中的应用. 中国医药工业杂志, 2025 , 56 (8) : 975 -983 . DOI: 10.16522/j.cnki.cjph.2025.08.001
Qinghui FU, Jie LIU, Jun HE. Nanoparticle Drug Delivery Systems for the Treatment of Metabolic Associated Fatty Liver Disease[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (8) : 975 -983 . DOI: 10.16522/j.cnki.cjph.2025.08.001
Year 2025 volume 56 Issue 8
49
17
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.08.001
  • Receive Date:2025-06-03
  • Online Date:2026-11-18
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-06-03
Funding
Affiliations
    National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.08.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT